pNETs
Showing 1 - 25 of 50
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)
Recruiting
- Multiple Endocrine Neoplasia Type 1
- Pancreatic Neuroendocrine Tumor
- EUS-guided fine-needle injection
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 24, 2022
Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning
Recruiting
- Nonfunctional Pancreatic Neuroendocrine Tumor
- +2 more
- EUS-guided ethanol ablation
- EUS-guided lauromacrogol ablation
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 30, 2022
Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 Trial in Marseille (Radiofrequency ablation)
Recruiting
- Neuroendocrine Tumor of Pancreas (Disorder)
- Neuroendocrine Tumor Grade 1
- Radiofrequency ablation
-
Marseille, FranceInstitut Paoli Calmettes
Jan 5, 2022
Multi-dimensional Fragmentomic Assay for Early Detection of
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Fragmentomic profiles of plasma cfDNA
- (no location specified)
Apr 27, 2023
Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail
Recruiting
- Non Functioning Pancreatic Endocrine Tumor
- Histopathological review, long-term prognosis and quality of life follow-up
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Jun 8, 2023
Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)
Active, not recruiting
- Medulloblastoma
- Neuroectodermal Tumor
- TTRNA-xALT
- TTRNA-DCs
-
Los Angeles, California
- +2 more
Jan 7, 2022
Pancreatic Neuroendocrine Tumour Metastatic Trial in Spain (Sunitinib)
Completed
- Pancreatic Neuroendocrine Tumour Metastatic
-
Oviedo, Asturias, Spain
- +8 more
Mar 3, 2020
Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)
Active, not recruiting
- Well Differentiated Pancreatic Endocrine Tumor
- Everolimus plus Octreotide LAR plus Metformin
-
Milano, ItalyFondazione IRCCS Istituto Tumori Milano
Sep 3, 2021
Nonfunctioning Small Neuroendocrine Pancreatic Incidentaloma
Active, not recruiting
- Neuroendocrine Tumors
-
Louvain, Belgium
- +21 more
Oct 8, 2021
Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)
Recruiting
- Pancreatic Neuroendocrine Tumor
- peptide receptor radionuclide therapy with Y-90-DOTATOC
-
Milano, Italy
- +1 more
Sep 30, 2022
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
Neuroendocrine Tumors, Tumors, Cancer Trial in Madison (TAS-102, Temozolomide, Filgrastim)
Active, not recruiting
- Neuroendocrine Tumors
- +3 more
- TAS-102
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Oct 29, 2021
Pancreatic Neuroendocrine Tumors in MEN1 Trial (Somatostatin-Analog)
Not yet recruiting
- Pancreatic Neuroendocrine Tumors in MEN1
- (no location specified)
Apr 5, 2019
Prognosis Between Pancreatic Neuroendocrine Tumors and
Completed
- Neuroendocrine Tumor of Pancreas
- +2 more
- No intervention
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
Jul 25, 2021
Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,
Completed
- Medulloblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Los Angeles, California
- +14 more
Jan 12, 2022
Asymptomatic Small Pancreatic Endocrine Neoplasms.
Recruiting
- Non Functioning Pancreatic Endocrine Tumor
- Radiological imaging studies
- Quality of Life Assessment
-
Milan, ItalyIRCCS San Raffaele Hospital
Mar 4, 2022
Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)
Completed
- Metastatic Medulloblastoma
- +2 more
- Carboplatin
- +2 more
-
Aurora, ColoradoChildren's Hospital Colorado
Dec 13, 2021
Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- +4 more
-
Ames, Iowa
- +5 more
Dec 3, 2021
Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided
Recruiting
- Neuroendocrine Tumor of Pancreas
- Multiple Endocrine Neoplasia Type 1
- High-dose-high precision MR-guided radiotherapy
-
Utrecht, NetherlandsUMC Utrecht
May 29, 2022
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Recruiting
- Unknown Primary Tumors
- DNA Methylation
-
Guangzhou, Guangdong, ChinaSun Yat-sen university cancer center
Nov 20, 2023
Lymph Node Metastases by NF-PanNENs
Recruiting
- Non Functioning Pancreatic Endocrine Tumor
-
Milan, ItalyIRCCS San Raffaele Hospital
Aug 23, 2022
Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- Unresectable Pancreatic Neuroendocrine Carcinoma
- Lutetium Lu 177 Dotatate
- +4 more
- (no location specified)
Feb 10, 2022